Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | +1.63% | +6.25% | -37.87% |
05-15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
05-14 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.87% | 36.65M | |
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.83% | 31.75B | |
+62.86% | 26.6B | |
-21.68% | 14.41B | |
-8.73% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Fortress Biotech : B. Riley Lowers Fortress Biotech's PT to $8 from $9, Says Incremental Pipeline Updates Suggest Heightened Focus on Next-Gen Therapies; Keeps Buy Rating